TAVICLA Trademark

Trademark Overview

On Monday, May 7, 2018, a trademark application was filed for TAVICLA with the United States Patent and Trademark Office. The USPTO has given the TAVICLA trademark a serial number of 87910173. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 15, 2021. This trademark is owned by Sarepta Therapeutics, Inc.. The TAVICLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
tavicla

General Information

Serial Number87910173
Word MarkTAVICLA
Filing DateMonday, May 7, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 15, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neuromuscular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 16, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSarepta Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSarepta Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, November 15, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 19, 2021EXTENSION 5 GRANTED
Tuesday, April 6, 2021EXTENSION 5 FILED
Monday, April 19, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 6, 2021TEAS EXTENSION RECEIVED
Wednesday, September 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 28, 2020EXTENSION 4 GRANTED
Monday, September 28, 2020EXTENSION 4 FILED
Monday, September 28, 2020TEAS EXTENSION RECEIVED
Tuesday, March 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 6, 2020EXTENSION 3 GRANTED
Friday, March 6, 2020EXTENSION 3 FILED
Friday, March 6, 2020TEAS EXTENSION RECEIVED
Wednesday, September 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2019EXTENSION 2 GRANTED
Monday, September 23, 2019EXTENSION 2 FILED
Monday, September 23, 2019TEAS EXTENSION RECEIVED
Thursday, March 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 26, 2019EXTENSION 1 GRANTED
Tuesday, March 26, 2019EXTENSION 1 FILED
Tuesday, March 26, 2019TEAS EXTENSION RECEIVED
Tuesday, October 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 14, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 14, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 3, 2018ASSIGNED TO EXAMINER
Wednesday, May 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 10, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

tavicla diseases disorders neuromuscular treatment preparations pharmaceutical